The group's principal activities are to research and develop pharmaceuticals and nutraceuticals for treatment of diseases and conditions associated with aging. The group's research has been focused on targeted antioxidant therapeutics for respiratory, neurological and cardiovascular diseases and the development of nutraceuticals for the dietary support of certain age-related conditions. The nutraceuticals aim at providing benefits through nutritious foods. The group owns registered trademarks for 'panvir', 'vantox' and the logo 'vyrex'.
